Hepatitis B Surface Antigen Loss during Treatment with Entecavir (Baraclude) or Lamivudine (Epivir-HBV)

Sign up to receive our twice-weekly e-Newsletter

HEPATITIS B TREATMENT GUIDELINES

	AASLD Issues Updated Practice Guidelines for Management of Chronic Hepatitis B 9/29/2009
	Treatment for Hepatitis B: When to Start, What to Use, and When to Stop 3/27/2009

Hepatitis B Main Section

FDA-approved Therapies for Chronic HBV Infection

Baraclude  (entecavir)
Epivir-HBV  (lamivudine; 3TC)
Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
Viread  (tenofovir)
Tyzeka   (telbivudine)

Experimental Treatments

HBV Articles by Topic

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation
Steatosis
Children / Infants / Women
Hepatitis B Clinical Trials
Experimental Treatments
FAQs About Hepatitis
Genotypes
Guidelines
Tests for HBV
Vaccines for HBV